Literature DB >> 27884786

Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia.

Tchilalo Boukpessi1, Betty Hoac2, Benjamin R Coyac3, Thibaut Leger4, Camille Garcia4, Philippe Wicart5, Michael P Whyte6, Francis H Glorieux7, Agnès Linglart8, Catherine Chaussain9, Marc D McKee10.   

Abstract

Seven young patients with X-linked hypophosphatemia (XLH, having inactivating PHEX mutations) were discovered to accumulate osteopontin (OPN) at the sites of defective bone mineralization near osteocytes - the so-called hallmark periosteocytic (lacunar) "halos" of XLH. OPN was also localized in the pericanalicular matrix extending beyond the osteocyte lacunae, as well as in the hypomineralized matrix of tooth dentin. OPN, a potent inhibitor of mineralization normally degraded by PHEX, is a member of a family of acidic, phosphorylated, calcium-binding, extracellular matrix proteins known to regulate dental, skeletal, and pathologic mineralization. Associated with the increased amount of OPN (along with inhibitory OPN peptide fragments) in XLH bone matrix, we found an enlarged, hypomineralized, lacuno-canalicular network - a defective pattern of skeletal mineralization that decreases stiffness locally at: i) the cell-matrix interface in the pericellular environment of the mechanosensing osteocyte, and ii) the osteocyte's dendritic network of cell processes extending throughout the bone. Our findings of an excess of inhibitory OPN near osteocytes and their cell processes, and in dentin, spatially correlates with the defective mineralization observed at these sites in the skeleton and teeth of XLH patients. These changes likely contribute to the dento-osseous pathobiology of XLH, and participate in the aberrant bone adaptation and remodeling seen in XLH.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Dentin; Mineralization; Osteocytic halos; Osteomalacia; PHEX; Rickets

Mesh:

Substances:

Year:  2016        PMID: 27884786     DOI: 10.1016/j.bone.2016.11.019

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  24 in total

1.  Osteopontin regulates dentin and alveolar bone development and mineralization.

Authors:  B L Foster; M Ao; C R Salmon; M B Chavez; T N Kolli; A B Tran; E Y Chu; K R Kantovitz; M Yadav; S Narisawa; J L Millán; F H Nociti; M J Somerman
Journal:  Bone       Date:  2017-12-05       Impact factor: 4.398

Review 2.  The role of biomineralization in disorders of skeletal development and tooth formation.

Authors:  Christopher S Kovacs; Catherine Chaussain; Philip Osdoby; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2021-05-04       Impact factor: 43.330

Review 3.  Hypophosphatemic osteosclerosis, hyperostosis, and enthesopathy associated with novel homozygous mutations of DMP1 encoding dentin matrix protein 1 and SPP1 encoding osteopontin: The first digenic SIBLING protein osteopathy?

Authors:  Michael P Whyte; S Deepak Amalnath; William H McAlister; Marc D McKee; Deborah J Veis; Margaret Huskey; Shenghui Duan; Vinieth N Bijanki; Suhas Alur; Steven Mumm
Journal:  Bone       Date:  2019-12-13       Impact factor: 4.398

Review 4.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

5.  Compositional and microhardness findings in tooth affected by X-linked hypophosphatemic rickets.

Authors:  Francisco-Samuel-Rodrigues Carvalho; Victor-Pinheiro Feitosa; Cristiane-Sá Roriz Fonteles; Thyciana-Rodrigues Ribeiro; Bruno-Sousa Araújo; Alejandro-Pedro Ayala; Fábio-Wildson-Gurgel Costa
Journal:  J Clin Exp Dent       Date:  2020-07-01

6.  Insights into dental mineralization from three heritable mineralization disorders.

Authors:  Michael B Chavez; Kaitrin Kramer; Emily Y Chu; Vivek Thumbigere-Math; Brian L Foster
Journal:  J Struct Biol       Date:  2020-08-03       Impact factor: 2.867

7.  Genetic and pharmacologic modulation of cementogenesis via pyrophosphate regulators.

Authors:  E Y Chu; T D Vo; M B Chavez; A Nagasaki; E L Mertz; F H Nociti; S F Aitken; D Kavanagh; K Zimmerman; X Li; P R Stabach; D T Braddock; J L Millán; B L Foster; M J Somerman
Journal:  Bone       Date:  2020-03-26       Impact factor: 4.398

8.  Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures.

Authors:  B R Coyac; B Hoac; P Chafey; G Falgayrac; L Slimani; P S Rowe; G Penel; A Linglart; M D McKee; C Chaussain; C Bardet
Journal:  J Dent Res       Date:  2017-09-07       Impact factor: 6.116

9.  Pulp chamber features, prevalence of abscesses, disease severity, and PHEX mutation in X-linked hypophosphatemic rickets.

Authors:  Giampiero I Baroncelli; Elisa Zampollo; Mario Manca; Benedetta Toschi; Silvano Bertelloni; Angela Michelucci; Alessandro Isola; Alessandra Bulleri; Diego Peroni; Maria Rita Giuca
Journal:  J Bone Miner Metab       Date:  2020-08-08       Impact factor: 2.626

Review 10.  Pharmacological management of X-linked hypophosphataemia.

Authors:  Erik A Imel; Kenneth E White
Journal:  Br J Clin Pharmacol       Date:  2018-10-29       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.